InvestorNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs
September 1, 2023
BiondVax (NASDAQ: BVXV), a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting IL-17 cytokines as treatments for psoriasis and psoriatic arthritis, recently received coverage in analysis by Aegis Capital Corp. The report, which reiterated a buy recommendation and $70 target price for BVXV, contained […]
InvestorNewsBreaks — GivBux Inc. (OTC: GBUX) Unveils One-of-a-Kind App that Combines Digital Commerce, Philanthropy
August 25, 2023
GivBux (OTC: GBUX) has launched a new app. The company has spent the last four years developing and testing the innovative super app, which is the first and only app of its kind. The GivBux app brings together brands, consumers and charities into what it calls a “unified economic ecosystem” that drives new business avenues […]
GolfLync Inc. Innovates Again by Creating the World’s First Virtual Golf Clubs(TM)
August 24, 2023
GolfLync, the innovative social media networking platform designed exclusively for golf enthusiasts, is ushering in a new era for the golfing community with its groundbreaking feature, Virtual Golf Clubs(TM) (“VGC”). This cutting-edge addition to the app empowers golfers to connect, share experiences, and create thriving golfing communities, making GolfLync the go-to destination for passionate golfers […]
Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Strategic Updates Concerning Patented DehydraTECH(TM) Technology
August 21, 2023
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced updates regarding its patented DehydraTECH(TM) technology – which improves the way that active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. Lexaria’s primary focus for DehydraTECH research and development […]
InvestorNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Spotlighted in New Cantor Fitzgerald Research Brief
August 17, 2023
RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution) (“UPNEEQ”), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults, is featured in a recent Cantor Fitzgerald research brief. Noting that the stock “looks even more interesting post solid quarter and ahead of potential […]
InvestorNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Announces Q2 2023 Results, Strategic Business Review Update
August 14, 2023
RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focused on the commercialization of UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. The company today announced financial results for the three months ended June 30, 2023, and provided an update on its business review. “During the […]
RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business Review
August 14, 2023
— UPNEEQ® remains a significant potential value driver given its rapid early acceptance by providers, large total addressable market and untapped consumer opportunity — — Executed financing amendment with Athyrium, which, subject to certain conditions, would provide meaningful flexibility as part of our ongoing strategy to invest in UPNEEQ and drive growth — — The […]
InvestorNewsBreaks — DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Releases Q2 2023 Financial Report
August 9, 2023
DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, is reporting its unaudited financial results for the second quarter ended June 30, 2023. Highlights of the report include revenues of $75.2 million, operating costs of $47.7 million, Adjusted EBITDA of $27.6 million, and net income of $24.4 […]
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Details About Public Offering, Begins Dosing in Final Phase 2 Trial Cohort
August 2, 2023
Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is reporting the price and size of the public offering it announced earlier this week. According to the company, 24,264,706 units of the company will be sold at a price of $0.34 […]
Sharing Services Global Corp. (SHRG) Subsidiary Unveils Two New Exclusive Product Offerings
July 31, 2023
Sharing Services Global’s (OTCQB: SHRG) wholly owned subsidiary, The Happy Co., has recently added to its exclusive product line. The company unveiled a new limited-time seasonal flavor for its popular energy drink PerX (https://ibn.fm/F3Lzz) and also launched a new probiotic dietary supplement product called Probio8 (https://ibn.fm/D6mqR). The Happy Co. is a leading producer and distributor […]
InvestorNewsBreaks – GolfLync Inc. Fostering Engagement Around Online Communities with Social Networking App
July 27, 2023
GolfLync is the company behind the GolfLync app – a social network for matching golf games and players and establishing groups with like-minded interests. “GolfLync designed its product to foster engagement around virtual online golf communities. Whether users aim to build a small team of individuals or larger groups with dozens of members, to golf […]
M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)
July 26, 2023
According to Goldman Sachs Research, the global pharmaceutical industry is sitting on about $700 billion in dealmaking firepower, expected to fuel M&A-driven growth as companies look to revamp their intellectual property portfolio as their existing patents expire (https://ibn.fm/7VNq6). Flush with cash, big drugmakers also have easy access to alternative financing, factors that allow them to […]
InvestorNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Reports on Annual General Meeting Results
July 21, 2023
Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, held its annual general meeting of stockholders on July 20, 2023, and is reporting on action taken during the meeting. According to the report, several proposals were ratified during the gathering, including Amir Adnani, Spencer Abraham, Vincent Della Volpe, David Kong, Gloria Ballesta and Trecia Canty being elected to […]
InvestorNewsBreaks — DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces Plans to Report Q2 2023 Results, Schedules Earnings Call
July 20, 2023
DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, anticipates releasing 2023 second-quarter financial results next month. According to the announcement, the company will release the report on Aug. 8, 2023, after market close. In addition, the company has scheduled a conference call and webcast to discuss […]
Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Looking to Empower Populations As Fintech Shifts Consumer and Businesses Purchasing Power
July 19, 2023
As early as 2016 – and perhaps even earlier – the signs were emerging of the disruption that financial technology, or FinTech, was set to cause in the market. “FinTech is a dynamic segment at the intersection of the financial services and technology sectors where technology-focused startups and new market entrants innovate the products and […]
GolfLync Inc. Drives Innovation in Social Golfing: New Golf App Connects Like-Minded Golfers Nationwide!
July 17, 2023
The surge in popularity of golf has opened a window of opportunity for online sports application developer GolfLync, the creator of a social networking app specifically attuned to establishing golf groups with like-minded interests, available for both Android and iOS users as a free download. Although great for finding individual partners and small groups, a […]
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces New Preclinical Data Further Demonstrating Unique Mechanism of Action for Itruvone (‘PH10’)
July 17, 2023
Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, today announced new mechanism of action data from a preclinical tissue distribution study in laboratory rats. According to the update, the study demonstrated that a single intranasal administration […]
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Sees Hot Market Potential for NanoAb Pipeline
July 12, 2023
The global dermatology pharmaceutics market was valued just over $20 billion in 2022 and is expected to surge to nearly $40 billion by 2030, growing at a CAGR of 8.91% during the forecast period (https://ibn.fm/A974K). Dermatology uses pharmaceuticals to control and treat numerous conditions that affect the skin, hair, nails, and more. BiondVax Pharmaceuticals (NASDAQ: […]
InvestorNewsBreaks – The Squire at Branches Opens Its Doors in Historic Locale in West Long Branch
July 11, 2023
The Squire at Branches, a full-service restaurant and bar located in West Long Branch, New Jersey, is now open. The new eating establishment is located within the event venue, Branches, where Squire’s Pub, a local favorite from the 1970s to the mid-1990s, previously operated. The Squire’s tagline — Savor the History. Taste the Future — was […]
The Squire at Branches in West Long Branch, N.J., is Now Open
July 11, 2023
WEST LONG BRANCH, N.J., July 11, 2023 (GLOBE NEWSWIRE) — via IBN – The Squire at Branches, a full-service restaurant and bar located at 123 Monmouth Road, West Long Branch, New Jersey, today announces that they are now open to the public. Located within the event venue, Branches, The Squire is where Squire’s Pub used to […]
Genprex Inc. (NASDAQ: GNPX) Reports Positive Results from its Phase 1 Acclaim-1 Clinical Trial; Releases Patient Video Describing Positive Experience
July 10, 2023
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with diabetes and cancer, recently disclosed favorable preliminary clinical data from the Phase 1 portion of its Acclaim-1 clinical trial. During the study, Genprex’s lead drug candidate, REQORSA(R), was well tolerated with no dose-limiting toxicities. In addition, the company reported […]
Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) Is ‘One to Watch’
July 7, 2023
Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) is a leading gold explorer in the Guiana Shield, South America. In early 2021, the company announced an exciting new greenfield gold discovery at its Oko West project in Guyana, where, after 22 months of resource definition drilling, the company has announced an initial Mineral Resource Estimate (“MRE”) containing […]
InvestorNewsBreaks – Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) Announces Corporate Update, $2M Debt Financing
July 5, 2023
Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF), a battery minerals company providing shareholders exposure to the global megatrend of electrification, has announced a debt financing arrangement. The company has arranged a $2 million gross proceeds debt financing arrangement with Weston Energy LLC, with proceeds of the financing earmarked for general working capital. The company issued […]
InvestorNewsBreaks – Cisco Systems Inc. (NASDAQ: CSCO) Featured in Yahoo! Finance Article
July 5, 2023
Cisco (NASDAQ: CSCO) was featured in a Yahoo! Finance article titled “3 stocks that could still light up 2023 just like July 4 fireworks.” The piece first discusses various S&P 500 performers, including stocks that have benefited from coming into the year in an oversold position, the excitement around AI, and earnings revision trends that […]
InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases FY 2023 Financial Report, Corporate Update
June 29, 2023
Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, is releasing its 2023 fiscal year report. Highlights of the report include positive results reported in the company’s phase 3 open label study of fasedienol (“PH94B”) in […]
Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Additional Findings in Diabetes Animal Study and Two Other R&D Programs
June 22, 2023
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, including the company’s patented DehydraTECH(TM) technology, recently reported additional findings from its diabetes animal study DIAB-A22-1, as well as updates on two other applied R&D programs for dementia (DEM-A22-1) and epilepsy (EPIL-A21-1). In March, Lexaria announced that it had completed initial testing using DehydraTECH-CBD […]
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Eyes Advancement of Itruvone into Phase 2B Development
June 21, 2023
Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, has announced favorable safety and tolerability data from its U.S. phase 1 clinical trial of itruvone. “PH10” is the company’s investigational rapid-onset pherine nasal spray for the treatment […]
InvestorNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTD) (FSE: 7HI) Announces Results of AGM
June 21, 2023
Hillcrest (CSE: HEAT) (OTCQB: HLRTD) (FSE: 7HI), an innovative clean technology company revolutionizing power conversion technologies and advanced control system solutions, today announced the results of voting at its annual general meeting (“AGM”) held Wednesday, June 20, 2023. According to the announcement, shareholders overwhelmingly voted in favor of all items put forward by the board […]
InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on Promising Results from Diabetes Animal Study
June 16, 2023
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is releasing additional findings from its DIAB-A22-1 study, a diabetes animal study designed to evaluate the company’s proprietary DehydraTECH-CBD. DehydraTECH is a patented drug-delivery formulation and processing platform technology developed by Lexaria. The company noted that in addition to the three positive outcomes reported earlier […]
InvestorNewsBreaks – Reunion Gold Corporation (TSX.V: RGD) (OTCQX: RGDFF) Reports on Annual Meeting Results, Releases Pit-Constrained Mineral Resource Estimate
June 14, 2023
Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) is reporting on its recent Annual General and Special Meeting of Shareholders, which was held June 13, 2023. During the meeting, shareholders elected nine individuals to serve on the company’s board of directors. Those individuals are David Fennell, Rick Howes, Elaine Bennett, Pierre Chenard, Richard Cohen, Adrian Fleming, Réjean Gourde, […]
Genprex Inc. (NASDAQ: GNPX) Announces Positive Data From Phase 1 Clinical Trial Evaluating REQORSA(R) Immunogene Therapy for Late-Stage Non-Small Cell Lung Cancer
June 14, 2023
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently announced that positive data from the Phase 1 portion of its Acclaim-1 clinical trial evaluating REQORSA(R) Immunogene Therapy in combination with Tagrisso(R) in late-stage non-small cell lung cancer (“NSCLC”) have been published in an abstract […]
InvestorNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Expected to Build on Growth Momentum with Larger Enterprise Contracts, ‘Highly Favorable’ Landscape
June 12, 2023
CISO Global Inc. (NASDAQ: CISO), a leading provider of global cybersecurity and compliance, was featured in a recent Cantor Fitzgerald equity research report. “Noting that the company is strategically positioned to fill the cybersecurity talent shortage gap, Cantor Research gave CISO an overweight rating and a $2 price target… The equity report noted CISO’s significant […]
InvestorNewsBreaks – Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) Announces Corporate Update, Secures Additional Funding to Assist in Punitaqui Project Development
June 7, 2023
Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF) (“BMR”) today provided a corporate update that detailed Cinabrio concessions at the Punitaqui Mine Complex, publication of its inaugural ESG (Environmental, Social and Governance) report on the BMR website, as well as its entry into an amendment to its existing bridge loan facility provided by Weston Energy LLC. […]
InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Presents Phase 3 SAD Study Results at ASCP Annual Meeting
June 1, 2023
Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, has reported the results of its phase 3 open-label study of fasedienol (“PH94B”) nasal spray for the treatment of adults with social anxiety disorder (“SAD”). The company […]
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Results of Phase 1 Clinical Trial Will Be Published at ASCO Meeting
May 26, 2023
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, is reporting on positive data gathered from the phase 1 portion of its Acclaim-1 clinical trial. The trial is designed to evaluate the company’s proprietary lead product candidate, REQORSA(R) Immunogene Therapy, in combination with Tagrisso(R) in […]
Lexaria Bioscience Corp. (NASDAQ: LEXX) Shareholders Approve Board Appointments Amid Push for Diversity; Vote to Endorse 6 Agenda Items in 2023 Annual Shareholder Meeting
May 26, 2023
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, on May 9 held its 2023 Annual Shareholder Meeting, in which 3,372,024 shares, constituting 56.3% of the company’s issued share capital, were represented. Carrying on with the theme of the previous year’s Annual Meeting, the virtual 2023 Annual Shareholder Meeting adhered to COVID-19 protocols, […]
METER Food Uncovers Major Findings Affecting Alternative Sweeteners Viability as Sugar Replacement
May 25, 2023
PULLMAN, Wash., May 25, 2023 (GLOBE NEWSWIRE) — via IBN — METER Food’s Research and Development Lab has published findings from a recent study exploring the pros and cons of top alternative sweeteners that food companies must consider when replacing sugar in product formulations. Pressure from consumers and governmental agencies to reduce the amount of sugar […]
InvestorNewsBreaks — DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces Anticipated $10K Donation to ASPCA(R)
May 24, 2023
DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, is donating $10,000 to the American Society for the Prevention of Cruelty to Animals (“ASPCA”). The donation is in support of the society’s mission to provide effective means for the prevention of cruelty to animals throughout the United States. The […]
InvestorNewsBreaks – Sharing Services Global Corporation’s (SHRG) Happy Co. Launches Tropical Twist Ahead of Summer Season
May 22, 2023
Sharing Services Global Corporation (OTCQB: SHRG) today announced that its wholly owned subsidiary The Happy Co., a leading producer and distributor of nootropic, functional beverage products with a focus on health and wellness, has released a new limited-time seasonal flavor for its popular energy drink PerX. The new flavor, Tropical Twist, is launching ahead of […]
Sharing Services Global Corporation (SHRG) Announces Launch of New Seasonal Flavor for The Happy Co.’s Energy Drink PerX
May 22, 2023
PLANO, Texas, May 22, 2023 (GLOBE NEWSWIRE) — via IBN — Sharing Services Global Corporation (OTCQB: SHRG) (the “Company”) today announces that its wholly owned subsidiary The Happy Co., a leading producer and distributor of nootropic, functional beverage products with a focus on health and wellness, has released a new limited-time seasonal flavor for its popular energy […]